Drug recall · June 12, 2013
Lamisil AT Cream recall
Why: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lamisil AT Cream (terbinafine hydrochloride 1% antifungal), 12 gm ( .42 oz) Tubes and 30 gm (1 oz) Tubes packaged in one box, Novartis Consumer Health, Inc., Parsitan, NJ. UPC code: 300676249438. (Club Pack), NDC 0067-6295-43
- Lots / codes
Lot #: 10109590, 10111050, Exp 2/28/13.
- Quantity
- 41,400 Boxes
- Company
- Novartis Consumer Health, Lincoln, NE
- Distribution
- Nationwide and Puerto Rico, and Panama. Military distribution made.
- Initiated
- February 19, 2013 · Voluntary: Firm initiated
- Classified
- June 6, 2013
- Reported
- June 12, 2013
- Ended
- November 26, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Terbinafine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.